Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis

Thorax

Volumn 52, Issue 7, 1997, Pages 634-637

  Van Woensel, Job B M ^a   Wolfs, Tom F W ^a   Van Aalderen, Wim M C ^a   Brand, Paul L P ^a   Kimpen, Jan L L ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Bronchiolitis; Corticosteroids; Respiratory syncytial virus; Treatment

Indexed keywords

PREDNISOLONE;

ARTICLE; ARTIFICIAL VENTILATION; BRONCHIOLITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INFANT; LENGTH OF STAY; MALE; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SYMPTOM;

EID: 0030858774     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.7.634     Document Type: Article

References (28)

1. Glezen WP, Denny FW. Epidemiology of acute lower respiratory disease in children. N Engl J Med 1973;288: 498-505.
2. Ruuskanen O, Ogra PL. Respiratory syncytial virus. Curr Probl Pediatr 1993;23:50-79.
3. Kimpen JLL, Heymans HSA. Respiratory syncytial virus: immunity and immune injury. Immunol Infect Dis 1993;3: 281-8.
4. Graham BS, Bunton LA, Wright PF, Karzon DT. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 1991;88:1026-33.
5. Garofalo R, Kimpen JLL, Welliver RC, Ogra PL. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr 1992;120:28-32.
6. Welliver RC, Tej TN, Ogra PL. The appearance of cell-bound IgE in respiratory tract epithelium after respiratory syncytial virus infection. N Engl J Med 1980;303:1198-202.
7. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Bjorksten B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995;95: 500-7.
8. Pullan CR, Hey EN. Wheezing, asthma and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. BMJ 1982;284:16659.
9. Springer C, Bar-Yishay E, Uwayyed K, Avital A, Vilozni D, Godfrey S. Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis. Pediatr Pulmonol 1990;9:181-5.
10. Tal A, Bavilski C, Yohai D, Bearman JE, Gorodischer R, Moses SW. Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics 1983; 71:13-8.
11. Leer JA, Green JL, Heimlich EM, Hyde JS, Moffet HL, Young GA, et al. Corticosteroid treatment in bronchiolitis. Am J Dis Child 1969;117:495-503.
12. De Boeck K, Van der Aa N, Van Lierde S, Corbeel L, Eeckels R. Respiratory syncytial virus bronchiolitis. A double blind dexamethasone efficacy study. Am J Respir Crit Care Med 1994;149:A345.
13. Dabbous IA, Tkachyk JS, Stamm SJ. A double blind study on the effects of Corticosteroids in the treatment of bronchiolitis. Pediatrics 1966;37:477-84.
14. Oski FA, Salitsky S, Barness LA. Steroid therapy in bronchiolitis: a double-blind study. Am J Dis Child 1961;102: 759.
15. Connolly JH, Field CMB, Glasgow JTF, Slattery CM, MacLynn DM. A double blind trial of prednisolone in epidemic bronchiolitis due to respiratory syncytial virus. Acta Paediatr Scand 1969;58:116-20.
16. Sussman S, Grossman M, Magofinn R, Shielbe J. Dexamethasone in obstructive respiratory tract infection in children: a controlled study. Pediatrics 1964;34:851.
17. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990;300:230-5.
18. Armitage P, Berry G. Statistical methods in medical research. 3rd ed. Oxford: Blackwell Scientific Publications, 1994: 195-204.
19. McIntosh K. Interferon in nasal secretions from infants with viral respiratory tract infections. J Pediatr 1978;93:33-6.
20. Hall CB, Douglas RG, Simons RL, Geiman JM. Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections. J Pediatr 1978; 93:28-32.
21. Anderson LJ, Tsou C, Potter C, Keyserling HL, Smith TF, Ananaba G, et al. Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. J Infect Dis 1994;170:1201-8.
22. Midulla F, Villani A, Panuska JR, Dab I, Kolls JK, Merolla R, et al. Respiratory syncytial virus lung infection in infants: immunoregulatory role of infected alveolar macrophages. J Infect Dis 1993;168:1515-9.
23. Wong DT, Rosenband M, Hovey K, Ogra PL. Respiratory syncytial virus infection in immunocompromised animals: implications in human infection. J Med Virol 1985;17: 359-70.
24. Schleimer RP. Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis 1990;141:s59-69.
25. Scarfone RJ, Fuchs SM, Nager AL, Shane SA. Controlled trial of oral prednisolone in emergency department treatment of children with acute asthma. Pediatrics 1993;92: 513-8.
26. Tibballs J, Shann FA, Landau LI. Placebo-controlled trial of prednisolone in children intubated for croup. Lancet 1992;340:745-8.
27. Rubin BK, Marcushamer S, Priel I, App EM. Emergency management of the child with asthma. Pediatr Pulmonol 1990;8:45-7.
28. Hall CB, Powell KR, MacDonald NE, Gala CL, Menegus ME, Suffin SC, et al. Respiratory syncytial virus infection in children with compromised immune function. N Engl J Med 1986;315:77-81.